Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Return on Sales (2016 - 2021)

Edesa Biotech's Return on Sales history spans 9 years, with the latest figure at 27665.71% for Q2 2021.

  • For Q2 2021, Return on Sales fell 2764965.0% year-over-year to 27665.71%; the TTM value through Jun 2021 reached 27665.71%, down 2764851.0%, while the annual FY2020 figure was 19.36%, N/A changed from the prior year.
  • Return on Sales for Q2 2021 was 27665.71% at Edesa Biotech, down from 98.1% in the prior quarter.
  • Across five years, Return on Sales topped out at 42.8% in Q4 2018 and bottomed at 27665.71% in Q2 2021.
  • The 5-year median for Return on Sales is 58.69% (2018), against an average of 2320.96%.
  • The largest annual shift saw Return on Sales soared 259352bps in 2020 before it crashed -2764965bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 68.37% in 2017, then skyrocketed by 163bps to 42.8% in 2018, then tumbled by -124bps to 10.15% in 2019, then tumbled by -349bps to 45.56% in 2020, then crashed by -60624bps to 27665.71% in 2021.
  • Per Business Quant, the three most recent readings for EDSA's Return on Sales are 27665.71% (Q2 2021), 98.1% (Q1 2021), and 45.56% (Q4 2020).